Results 121 to 130 of about 25,326 (255)
Background Malignant melanoma of the uveal tract is a rare malignancy but a significant cause of mortality and visual loss. Approximately 50% of patients diagnosed with a melanoma of the choroid or ciliary body will die of the disease within 15 years of ...
Marilyn C. Kincaid
core +1 more source
Malignant craniopharyngiomas: Institutional experience and literature review
We report the second case of malignant craniopharyngioma with BAP1 and TP53 mutations. A literature review identified 44 cases of malignant craniopharyngiomas with a median overall survival of 6 months. Eighteen (41%) occurred in patients without any history of radiation, suggesting that mechanisms other than radiation have contributed to their ...
Thomas J. Auen +10 more
wiley +1 more source
Uveal melanoma: epidemiology, etiology, and treatment of primary disease
Benjamin A Krantz,1 Nikita Dave,2 Kimberly M Komatsubara,2 Brian P Marr,3,4 Richard D Carvajal5 1Division of Hospital Medicine, 2Division of Hematology/Oncology, Columbia University Medical Center, 3Ophthalmic Oncology Service, Memorial Sloan Kettering ...
Carvajal RD +4 more
core
Testing patients with uveal melanoma for herpesvirus infections
Results of comprehensive ELISA tests of blood serum for the presence of IgM-, IgA-, and IgG-antibodies to herpes simplex virus types 1 and 2, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, human herpes virus 8 type, Chlamydia trachomatis in 38
S. V. Saakyan +7 more
doaj +1 more source
Exoresection and endoresection for uveal melanoma
Surgical resection of uveal melanomas is an alternative eye-salvaging approach to the more commonly used irradiation techniques. There are two surgical resection techniques: Transscleral resection or "Exoresection" via a partial lamellar sclerouvectomy and "Endoresection" via a pars plana vitrectomy.
Gündüz, Kaan, Bechrakis, Nikolaos E.
openaire +3 more sources
A 51‐year‐old female presenting with headache and vision loss
Headache: The Journal of Head and Face Pain, EarlyView.
Laurel Ovrom +3 more
wiley +1 more source
ABSTRACT The 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting took place in Amsterdam, The Netherlands on October 25th, 2025. Several promising drug candidates are in development; however, there is still an urgent need for better prevention, detection, and treatment of uveal melanoma.
Andrew E. Aplin +18 more
wiley +1 more source
Uveal melanoma: a model for exploring fundamental cancer biology.
Recent studies have revealed that that uveal melanoma and cutaneous melanoma are remarkably different diseases. Uveal Melanoma: A Model for Exploring Fundamental Cancer Cell Biology provides insights into some of these differences and summarizes recent ...
GRAMMATICO, Paola, M. A. BLASI
core
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
BackgroundScreening for gene mutations has become routine clinical practice across numerous tumor entities, including melanoma. BAP1 gene mutations have been identified in various tumor types and acknowledged as a critical event in metastatic uveal ...
Johanna Matull +25 more
doaj +1 more source
Many types of cancers metastasize to the eye. However, uveal melanoma metastasizing to the contralateral choroid is very rare. We report the case of a 68-year-old man with history of treated uveal melanoma of the right eye that developed metastasis to ...
Nouritza M. Torossian +3 more
doaj +1 more source

